A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG).

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG). J Thorac Oncol. 2015 Jan; 10(1):143-7.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Erlotinib Hydrochloride
Female
Humans
Induction Chemotherapy
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Paclitaxel
Quinazolines
Radiotherapy Dosage
Radiotherapy, Adjuvant

authors with profiles

Everett E. Vokes